Stay updated on Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows recruitment status as No longer looking for participants. The Intervention/Treatment label is standardized (replacing Intervention / Treatment) and the revision tag updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T08:36:53.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's revision history now includes a new entry 'Revision: v3.5.5' and removes the previous 'Revision: v3.5.4' entry. This update represents a minor administrative change to the page metadata rather than user-facing content or functionality.
    Difference
    0.1%
    Check dated 2026-06-08T04:30:25.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    This page now shows Revision: v3.5.4, replacing the previous v3.5.3 revision. This indicates a small update to the page record without altering the study details or required actions for participants.
    Difference
    0.1%
    Check dated 2026-05-17T10:46:41.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    This change updates the ClinicalTrials.gov page revision version from v3.5.2 to v3.5.3, reflecting a site/software metadata update rather than a change to the underlying study record content.
    Difference
    0.1%
    Check dated 2026-04-25T18:35:38.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:25:47.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    - Version history updated: Revision v3.5.0 added; Revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-21T00:52:23.000Z thumbnail image

Stay in the know with updates to Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.